NO20010105D0 - Nye antibakterielle forbindelser - Google Patents

Nye antibakterielle forbindelser

Info

Publication number
NO20010105D0
NO20010105D0 NO20010105A NO20010105A NO20010105D0 NO 20010105 D0 NO20010105 D0 NO 20010105D0 NO 20010105 A NO20010105 A NO 20010105A NO 20010105 A NO20010105 A NO 20010105A NO 20010105 D0 NO20010105 D0 NO 20010105D0
Authority
NO
Norway
Prior art keywords
compounds
antibacterial compounds
new antibacterial
xvi
xiv
Prior art date
Application number
NO20010105A
Other languages
English (en)
Other versions
NO322083B1 (no
NO20010105L (no
Inventor
Masatoshi Inukai
Masakatsu Kaneko
Toshio Takatsu
Hitoshi Hotoda
Masatoshi Arai
Shunichi Miyakoshi
Masaaki Kizuka
Yasumasa Ogawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20010105D0 publication Critical patent/NO20010105D0/no
Publication of NO20010105L publication Critical patent/NO20010105L/no
Publication of NO322083B1 publication Critical patent/NO322083B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/167—Heterorings having sulfur atoms as ring heteroatoms, e.g. vitamin B1, thiamine nucleus and open chain analogs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
NO20010105A 1998-07-09 2001-01-08 Nye antibakterielle forbindelser, farmasoytisk akseptable forbindelser av disse, anvendelse ved fremstilling av et medikament, fremgangsmate for fremstilling, samt mikroorganisme. NO322083B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19428598 1998-07-09
JP26944598 1998-09-24
PCT/JP1999/003718 WO2000002892A1 (en) 1998-07-09 1999-07-09 Novel antibacterial compounds

Publications (3)

Publication Number Publication Date
NO20010105D0 true NO20010105D0 (no) 2001-01-08
NO20010105L NO20010105L (no) 2001-03-08
NO322083B1 NO322083B1 (no) 2006-08-14

Family

ID=26508414

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010105A NO322083B1 (no) 1998-07-09 2001-01-08 Nye antibakterielle forbindelser, farmasoytisk akseptable forbindelser av disse, anvendelse ved fremstilling av et medikament, fremgangsmate for fremstilling, samt mikroorganisme.

Country Status (23)

Country Link
US (2) US6472384B1 (no)
EP (3) EP1319406A1 (no)
KR (2) KR100729196B1 (no)
CN (1) CN1181087C (no)
AT (2) ATE356825T1 (no)
AU (1) AU751470B2 (no)
BR (1) BR9911965A (no)
CA (1) CA2337225C (no)
DE (2) DE69935513T2 (no)
DK (2) DK1319666T3 (no)
ES (2) ES2284260T3 (no)
HK (2) HK1053063A1 (no)
HU (1) HUP0103711A3 (no)
ID (1) ID27955A (no)
IL (3) IL140731A0 (no)
NO (1) NO322083B1 (no)
NZ (1) NZ509233A (no)
PL (1) PL200426B1 (no)
PT (1) PT1095947E (no)
RU (1) RU2209210C2 (no)
TR (1) TR200100059T2 (no)
WO (1) WO2000002892A1 (no)
ZA (1) ZA200100200B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI245047B (en) * 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives
WO2002024491A1 (de) 2000-09-25 2002-03-28 Volkswagen Ag Airbagvorrichtung und betriebsverfahren dafür
US7652039B2 (en) * 2002-05-17 2010-01-26 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious disease
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
WO2005034857A2 (en) * 2003-09-05 2005-04-21 Sequella, Inc. Methods and compositions comprising diamines as new anti-tubercular therapeutics
US8168635B2 (en) * 2004-06-19 2012-05-01 Human Biomolecular Research Institute Modulators of central nervous system neurotransmitters
US20090068325A1 (en) * 2007-09-10 2009-03-12 Gil Depicciotto Method of treatment of fresh produce
WO2009136965A1 (en) * 2008-05-06 2009-11-12 Sequella, Inc. Compositions and methods comprising capuramycin analogues

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60259190A (ja) * 1984-06-06 1985-12-21 Kanto Ishi Pharma Co Ltd 新抗生物質カプラマイシン及びその製造法
US5034381A (en) 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
JPH05148293A (ja) * 1991-11-28 1993-06-15 Mect Corp 新規カプラマイシン誘導体およびその製造方法
GB9307043D0 (en) 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
TWI245047B (en) 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives

Also Published As

Publication number Publication date
ZA200100200B (en) 2002-06-26
HK1053127A1 (en) 2003-10-10
DE69935513T2 (de) 2007-11-29
NZ509233A (en) 2003-05-30
CN1317008A (zh) 2001-10-10
IL140731A0 (en) 2002-02-10
EP1319406A1 (en) 2003-06-18
ATE356825T1 (de) 2007-04-15
EP1319666A1 (en) 2003-06-18
EP1095947A4 (en) 2002-01-16
ID27955A (id) 2001-05-03
HUP0103711A3 (en) 2003-11-28
US6472384B1 (en) 2002-10-29
BR9911965A (pt) 2001-05-29
IL187551A (en) 2009-12-24
DK1095947T3 (da) 2007-07-16
HK1053063A1 (zh) 2003-10-10
CN1181087C (zh) 2004-12-22
HUP0103711A2 (hu) 2002-02-28
CA2337225A1 (en) 2000-01-20
KR100622889B1 (ko) 2006-09-12
DE69935513D1 (de) 2007-04-26
ATE304548T1 (de) 2005-09-15
US6844173B2 (en) 2005-01-18
EP1095947B1 (en) 2007-03-14
US20030069204A1 (en) 2003-04-10
AU751470B2 (en) 2002-08-15
EP1319666B1 (en) 2005-09-14
AU4650599A (en) 2000-02-01
TR200100059T2 (tr) 2001-05-21
CA2337225C (en) 2009-05-26
HK1053127B (zh) 2005-12-30
DK1319666T3 (da) 2005-12-05
EP1095947A1 (en) 2001-05-02
PL200426B1 (pl) 2009-01-30
NO322083B1 (no) 2006-08-14
DE69927306T2 (de) 2006-07-06
ES2284260T3 (es) 2007-11-01
KR20060011919A (ko) 2006-02-03
IL140731A (en) 2008-06-05
PT1095947E (pt) 2007-06-20
WO2000002892A1 (en) 2000-01-20
ES2248654T3 (es) 2006-03-16
KR100729196B1 (ko) 2007-06-19
IL187551A0 (en) 2008-03-20
KR20010083101A (ko) 2001-08-31
NO20010105L (no) 2001-03-08
RU2209210C2 (ru) 2003-07-27
PL345403A1 (en) 2001-12-17
DE69927306D1 (de) 2005-10-20

Similar Documents

Publication Publication Date Title
IL187551A0 (en) Antimicrobial capuramycin derivatives and pharmaceutical compositions containing the same
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
GEP20063831B (en) Substituted bicyclic derivatives for treatment of abnormal cell growth
DE69928952D1 (de) Chinolin-derivate und ihre verwendung als antibakterielle wirkstoffe
ATE233274T1 (de) Oxyiminopregnancarbolactone
NZ506058A (en) Antibacterial 9-substituted tetracyclines, and pharmaceuticals and uses thereof
NO983074L (no) Karbamoyloksyderivater av mutilin og deres anvendelse som antibakterielle midler
MX9803650A (es) Agentes antimicrobianos de benzoxazina.
GEP20094834B (en) Macrolides, pharmaceutical compositions containing them and their use for treatment of bacterial infections
MX9708611A (es) Compuestos de dialquiltiacumicina.
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
ES2115424T3 (es) Derivados prolin-amidicos basicos de los antibioticos ge 2270 y similares a ge 2270.
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
NO20045373L (no) Cyanoguanidinprodroger
MD1788G2 (ro) Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase
ATE250610T1 (de) Kaliumkanal-blockierende mittel
FR2412564A1 (fr) Nouvelles 2' -n-acyl- et alkyl-6' -n-alkyl- et 6', 6' -di-n-alkyl-fortimicines a et b, utiles notamment comme antibiotiques
ES2108022T3 (es) Un nuevo antibiotico, balimicina, un procedimiento para su produccion y su utilizacion como producto farmaceutico.
ATE390490T1 (de) Antibiotika-ge-81112-faktoren a, b, b1, pharmazeutisch unbedenkliche salze und zusammensetzungen sowie verwendungen davon
MD1105C2 (ro) N-(5-Nitro-2-furfuriliden)-4-aminobenzensulfamide, care manifestă activitate antimicrobiană
JPS57109786A (en) Antibiotic c-19393e5 and its preparation
ECSP993176A (es) Nuevos compuestos y composiciones antibacterianas

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees